Maze Therapeutics (MAZE) Revenue & Revenue Breakdown
Maze Therapeutics Revenue Highlights
Latest Revenue (Y)
$167.50M
Maze Therapeutics Revenue by Period
Maze Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $167.50M | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | - |
Maze Therapeutics generated $167.50M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Maze Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | -100.00% |
| 2024-09-30 | $2.50M | -98.48% |
| 2024-06-30 | $165.00M | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | - |
Maze Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Maze Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ARDX | Ardelyx | $333.62M | $97.66M |
| MAZE | Maze Therapeutics | $167.50M | - |
| WVE | Wave Life Sciences | $108.30M | $8.70M |
| IMTX | Immatics | $54.00M | $30.45M |
| NBTX | Nanobiotix | $30.06M | $30.06M |
| TSHA | Taysha Gene Therapies | $8.33M | $1.99M |
| NUVB | Nuvation Bio | $7.87M | $4.83M |
| ELVN | Enliven Therapeutics | - | - |
| SION | Sionna Therapeutics | - | - |
| TRML | Tourmaline Bio | - | - |
| ORIC | ORIC Pharmaceuticals | - | - |